Holen Sie sich die Stockscreener-App
27.86
0.29%
0.07
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit? - TradingView
Novartis India to Acquire Pfizer’s BP Drug Brands for ₹1,250 Crore - Chemical Industry Digest
Mandi Rollerson Takes on New AI Change and Adoption Leadership Role at Pfizer - hrtoday.in
Why Pfizer Stock Was so Healthy in August - Yahoo Finance
Inside Pfizer’s Fight Against Counterfeit Medicine - Pfizer
Why Pfizer Stock Was so Healthy in August - The Motley Fool
Why Is Pfizer (NYSE:PFE) Trading At Such A Wide Discount To Its Healthcare Peers? - Kalkine Media
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference - Business Wire
💊 Pfizer to discontinue Minipress XL in India 🤝 Novartis India buys the brand for ₹1,250 crore 📉 But Pfizer India gets just ₹131 crore of the deal Ekta Batra #Pfizer #Novartis #MinipressXL #PfizerIndia #NovartisIndia #CNBCTV18Digital - LinkedIn
Precision Trading with Pfizer Inc. (PFE) Risk Zones - Stock Traders Daily
Novartis India acquires Pfizer brands for $132m - Yahoo Finance
Pfizer shares hit 52-week low after Minipress XL discontinuation; Novartis zooms 13% - Business Today
Novartis India to Acquire Minipress, Minipres Trademarks From Pfizer for Rs 1,250 Crore - Medical Dialogues
Pfizer to Discontinue Minipress XL in India, Receives USD 13.9 Mn From US Parent - Medical Dialogues
Pfizer stock heads into the open after a flat close - AD HOC NEWS
Pfizer (PFE) Hands Broad Rights On CD228V In New Oncology Licensing Deal - simplywall.st
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now - Yahoo Finance
Maharashtra: Novartis India buys Minipress brands from Pfizer for Rs 1250 crore - Deccan Chronicle
This Is What I'd Do With Pfizer Stock Right Now - The Globe and Mail
Novartis India to Acquire Pfizer’s Minipress Trademarks for Rs 1,250 Crore - chemanalyst.com
Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for ₹1,250 crore - BusinessLine
ChrysCap-controlled Novartis India to buy Pfizer’s blood pressure brand Minipress - VCCircle
Novartis India buys Minipress brands from Pfizer for ₹1,250 crore - Business Standard
Novartis India to acquire Pfizer's 'Minipress' trademark for ₹1,250 crore - ET Manufacturing
Novartis India to Buy Pfizer’s Minipress Brand for Rs 1,250 Cr - Equitypandit
Pfizer Inc. stock gains on Minipress XL exit and solid Q2 2026 figures - AD HOC NEWS
Novartis India to acquire Minipress, Minipres Trademarks from Pfizer for Rs 1,250 crore - Business Upturn
Novartis India: Why Is the Pharma Stock Spending ₹1,250 Crore to Acquire Pfizer’s Minipress Brand? - Trade Brains
Pfizer, Inc. (PFE) Stock Analysis: Evaluating the 6.05% Dividend Yield and Its Implications for Investors - DirectorsTalk Interviews
Novartis India Expands Portfolio With INR 1,250 Crore Acquisition of Pfizer's Minipress Trademarks - latestly.com
Pfizer to Receive Rs 131.38 Crore After Minipress XL Discontinuation; Know Details - Dalal Street Investment Journal
Novartis India to acquire Pfizer trademarks 'Minipress' and 'Minipres' for Rs 1,250 crore - Mid-Day
Novartis India buys Minipress, Minipres rights from Pfizer for ₹1,250cr - NewsBytes
Novartis India Buys Minipress From Pfizer For ₹1,250 Crore - Whalesbook
Minipress changes hands: Novartis India buys Pfizer brands for Rs 1,250 crore - Moneycontrol.com
Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore - The Economic Times
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore - BusinessLine
Pfizer to cease Minipress XL operations, secures USD 13.9 million from US parent - Business Upturn
Novartis India Acquires Pfizer's Minipress for ₹1,250 Cr - Rediff MoneyWiz
Novartis India shares jump 4% on Rs 1,250 crore Pfizer trademarks acquisition - Business Today
Novartis India Buys Minipress Brand For ₹1,250 Crore, Pfizer To Stop Selling Hypertension Drug - Free Press Journal
Pfizer to Discontinue Minipress XL, Receives $13.9M - InvestyWise
Novartis India to acquire Minipress, Pfizer’s high blood pressure drug, for ₹1,250 crore - CNBC TV18
News by CNBC TV18 on TradingView, 2026-09-07 — cnbctv:e8e1f8f6f094b:0 - TradingView
Pfizer Limited To Stop Selling Minipress XL; To Receive ₹131.38 Crore Payment - Sahi
Novartis India acquires Pfizer Minipress IP rights for ₹1,250 crore - scanx.trade
Pfizer discontinues Minipress XL sales, to receive $13.9 million - scanx.trade
Pfizer Ltd to Discontinue Minipress XL; Receives Rs 131 Crore Compensation - Whalesbook
PFE Stock Quote Price and Forecast - CNN
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Pfizer Stock Price Forecast. Should You Buy PFE? - StockInvest.us
Pfizer (NYSE:PFE): Is Today’s Rally Hiding A Bigger Market Shift? - Kalkine Media
Pfizer Inc. stock underperforms Friday when compared to competitors - MarketWatch
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors - TipRanks
Pfizer Must Include Interest Payments in Alabama Taxable Income - news.bloombergtax.com
Pfizer (NYSE:PFE) Vaccine Approval Puts Valuation In Focus - Kalkine Media
Pfizer’s Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying? - Yahoo Finance
0.11%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):